by Susan Keown | Nov 2, 2024 | ScienceWire
A story by Lisa Stiffler in GeekWire explains how Everett company TerraPower Isotopes has managed to produce a rare cancer-drug ingredient, actinium-225, from nuclear waste. Though it has access to only the equivalent of 17 pennies’ in weight of source material from...
by Susan Keown | Nov 2, 2024 | ScienceWire
Mark Harris writes a decarbonization newsletter for Anthropocene Magazine, “Fixing Carbon: Dispatches From an Emerging Future,” which examines issues in climate technology and economics. His two October issues ask whether tariffs on foreign EVs and low-carbon...
by Susan Keown | Sep 30, 2024 | ScienceWire
Ian Haydon is leading the production of a new podcast from Dr. David Baker’s lab at the University of Washington, whose goal is to shine a spotlight on the people behind the group’s work on protein design. Haydon leads all aspects of the show, including planning,...
by Susan Keown | Sep 30, 2024 | ScienceWire
The uncomely vulture has immense human benefit, writes Ian Rose for the Washington Post. He reports on new research on the effects of a mass poisoning of vultures across India after the widespread adoption of an antiinflammatory drug in livestock. Small amounts of the...
by Susan Keown | Sep 30, 2024 | ScienceWire
For Slate, Katie MacBride traces a thread from the publication of the groundbreaking book “Silent Spring” through today’s wellness influencers touting “all-natural” products. She examines the connotation of “chemical” with “toxic” and, conversely, “natural” with...
by Susan Keown | Sep 30, 2024 | ScienceWire
In a piece for The Atlantic, Eric Scigliano stumbles on a natural experiment in his Seattle neighborhood: residential blocks built, unusually, with no streetlights. He compares the crime rates on these blocks and nearby lit blocks and investigates what cities around...
